What are the physiology, pathophysiology, causes, and differential diagnosis of internuclear ophthalmoplegia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Internuclear Ophthalmoplegia: Physiology, Pathophysiology, Causes, and Differential Diagnosis

Normal Physiology

The medial longitudinal fasciculus (MLF) is a highly myelinated microscopic tract in the brainstem that coordinates conjugate horizontal eye movements by connecting the abducens nucleus (CN VI) on one side to the contralateral oculomotor nucleus (CN III). When you look to the right, the right abducens nucleus fires to activate the right lateral rectus muscle while simultaneously sending signals through the MLF to the left oculomotor nucleus, which activates the left medial rectus muscle—creating coordinated rightward gaze 1, 2.

Pathophysiology

INO occurs when a lesion disrupts the MLF, breaking the connection between the abducens and contralateral oculomotor nuclei, resulting in failure of adduction on the affected side with dissociated nystagmus in the abducting eye 3, 2.

Key pathophysiological features:

  • The MLF is so small and densely myelinated that inflammatory lesions can cause significant functional conduction blocks that fall below the resolution threshold of standard 1.5T or 3T MRI 4
  • This creates clinical-radiographic dissociation where pathognomonic physical findings exist despite negative neuroimaging 4
  • Bilateral INO indicates lesions affecting both MLFs, typically in the dorsal pons 5

Clinical Presentation

The pathognomonic triad consists of:

  • Failure of adduction of the affected eye during horizontal gaze
  • Dissociated nystagmus in the abducting (contralateral) eye
  • Impaired convergence (though this may be preserved in some cases) 4, 3

Patients typically present with:

  • Binocular horizontal diplopia
  • Vertigo or dizziness 5
  • Oscillopsia (visual world appears to jump)

Causes and Differential Diagnosis

The differential diagnosis of INO should be tripartite: multiple sclerosis, stroke, and other causes—with unusual causes comprising more than one quarter of all cases 6.

Primary Causes by Age and Laterality:

Bilateral INO:

  • Multiple sclerosis is the leading cause, particularly in younger patients (73% of bilateral cases in MS patients) 6
  • Serves as a "red flag" for MS or other central demyelinating events, especially in pediatric populations 4

Unilateral INO:

  • Stroke/ischemic infarction is the predominant cause in elderly patients (87% of stroke-related INO is unilateral) 6, 5
  • Typically involves perforating arteries supplying the dorsal pons 5

Unusual Causes (28% of all cases) 6:

  • Trauma (20 cases in series): Blunt head trauma causing MLF infarction from perforating artery injury or transient vasospasm 7
  • Tentorial herniation (20 cases): Compressive injury to brainstem
  • Infection (17 cases): Brainstem infections
  • Tumor (17 cases): Brainstem and fourth ventricular tumors 3
  • Iatrogenic injury (12 cases): Surgical complications
  • Hemorrhage (13 cases): Brainstem hemorrhage
  • Vasculitis (7 cases): Including lupus erythematosus 3
  • Miscellaneous (8 cases): Arnold-Chiari malformation, hydrocephalus 3

Diagnostic Approach

When pathognomonic physical findings of INO are present, they must supersede nonspecific or negative imaging findings 4.

Clinical Examination Priority:

  1. Perform oculocephalic maneuvers (doll's eye test): If these move the eyes appropriately, the lesion is supranuclear, not INO 2
  2. Document the characteristic triad of adduction failure, dissociated nystagmus, and convergence abnormality
  3. Determine unilateral vs. bilateral involvement (critical for narrowing differential)

Imaging:

  • MRI with diffusion-weighted imaging is the method of choice for visualizing MLF lesions 3, 7
  • However, negative MRI does not exclude INO—the MLF may be too small to visualize the lesion 4
  • In demyelinating disease, look for periventricular white matter hyperintensities 8, 4

Laboratory Workup (especially for bilateral INO):

  • CSF analysis: Oligoclonal bands present in 80-90% of MS patients vs. 20-40% in NMOSD 8
  • Serum NMO-IgG (anti-AQP4 antibodies): 76% sensitive and 94% specific for neuromyelitis optica spectrum disorders 8
  • CSF pleocytosis (≥50 leukocytes/mm³) suggests NMOSD over MS 8

Management Considerations

For suspected demyelinating INO with negative imaging, empiric treatment with high-dose intravenous methylprednisolone is appropriate to facilitate blood-brain barrier stabilization and address inflammatory demyelination 4.

Conservative Management:

  • Occlusion is the most common symptomatic treatment for diplopia (45.5% of cases) 9
  • Prisms for symptomatic relief (24.2% of cases) 9
  • 30% of patients require no orthoptic intervention 9

Natural History:

  • Traumatic isolated INO may resolve completely within 48 hours without specific treatment 7
  • Stroke-related INO often shows gradual improvement
  • MS-related INO may fluctuate with disease activity

Surgical Management:

  • Reserved for persistent symptomatic bilateral INO
  • Can achieve binocular single vision post-operatively with adjunctive Fresnel prisms 9
  • Limited evidence base; outcomes vary by technique 9

Critical Pitfalls

  • Do not dismiss INO diagnosis based on negative MRI alone—clinical findings are paramount 4
  • Bilateral INO in young patients demands aggressive MS workup, even with minimal imaging findings 4
  • Unilateral INO in elderly patients is stroke until proven otherwise 6, 5
  • Approximately 15% of patients presenting with "dizziness" have dangerous underlying causes—INO with vertigo warrants immediate stroke evaluation 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.